Importantly, this prognostic value of CXCR4 was independent of IPI score, ABC/GCB classification, CD20 expression and, for GCB-DLBCL patients, the CC and CB subtypes of our recently defined BAGS classification system. Here, CXCR4 is linked to diffuse large B-cell lymphoma.